De Novo DSA in the Setting of Stable Renal Allograft Function is a Benign Finding
Sign Up to like & getrecommendations! Published in 2018 at "Transplantation"
DOI: 10.1097/01.tp.0000542596.39174.b7
Abstract: We sought to determine the long-term outcome of renal allograft recipients that developed de novo DSA (dnDSA) in the setting of stable allograft function. Methods A retrospective single-center review of 150 consecutive renal allograft recipients… read more here.
Keywords: graft; dndsa; allograft; renal allograft ... See more keywords
An Increase in Low-Grade Spot Urine Protein Excretion During the First Year after Kidney Transplantation Associates with Subclinical De-Novo Donor-Specific Antibodies and Microvascular Inflammation at 1-Year Surveillance Biopsies
Sign Up to like & getrecommendations! Published in 2018 at "Transplantation"
DOI: 10.1097/01.tp.0000542868.99891.0d
Abstract: The presence of microvascular inflammation (MVI) in kidney transplant biopsies often relates to occurrence of donor-specific antibodies (DSA) and antibody-mediated rejection. Here we investigated whether an increase in spot urine protein excretion during the first… read more here.
Keywords: first year; mvi; year surveillance; year ... See more keywords
Preformed and de novo DSA are associated with T‐cell–mediated rejection in pediatric liver transplant recipients requiring clinically indicated liver biopsy
Sign Up to like & getrecommendations! Published in 2019 at "Pediatric Transplantation"
DOI: 10.1111/petr.13611
Abstract: Despite growing interest about the impact of donor‐specific HLA antibodies (DSA) in LT limited data are available for pediatric recipients. Our aim was to perform a retrospective single‐center chart review of children (0‐16 years) having… read more here.
Keywords: tcmr; preformed novo; dsa; liver ... See more keywords
Antibody-removal therapies for de novo DSA in pediatric intestinal recipients: Why, when, and how? A single-center experience
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Pediatrics"
DOI: 10.3389/fped.2022.1074577
Abstract: Background Donor-specific anti-HLA antibodies (DSA) impact negatively on the outcome of intestinal grafts. Although the use of antibody-removal therapies (ART) is becoming more frequent in the last few years, issues regarding their timing and effectiveness… read more here.
Keywords: antibody removal; experience; novo dsa; removal ... See more keywords